nodes	percent_of_prediction	percent_of_DWPC	metapath
Indinavir—SLC22A1—Cladribine—multiple sclerosis	0.0784	0.104	CbGbCtD
Indinavir—ABCC1—Mitoxantrone—multiple sclerosis	0.0726	0.096	CbGbCtD
Indinavir—SLCO1A2—Prednisolone—multiple sclerosis	0.057	0.0754	CbGbCtD
Indinavir—SLCO1A2—Prednisone—multiple sclerosis	0.0539	0.0712	CbGbCtD
Indinavir—CYP2D6—Fingolimod—multiple sclerosis	0.0351	0.0464	CbGbCtD
Indinavir—SLCO1A2—Dexamethasone—multiple sclerosis	0.0336	0.0444	CbGbCtD
Indinavir—ABCC1—Methotrexate—multiple sclerosis	0.0303	0.04	CbGbCtD
Indinavir—ABCC2—Dexamethasone—multiple sclerosis	0.0279	0.0368	CbGbCtD
Indinavir—SLCO1A2—Methotrexate—multiple sclerosis	0.027	0.0357	CbGbCtD
Indinavir—SLCO1B1—Methotrexate—multiple sclerosis	0.0255	0.0337	CbGbCtD
Indinavir—ABCB1—Methylprednisolone—multiple sclerosis	0.024	0.0318	CbGbCtD
Indinavir—ABCC2—Methotrexate—multiple sclerosis	0.0224	0.0296	CbGbCtD
Indinavir—CYP3A4—Fingolimod—multiple sclerosis	0.0223	0.0295	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0186	0.0246	CbGbCtD
Indinavir—CYP3A7—Dexamethasone—multiple sclerosis	0.0186	0.0246	CbGbCtD
Indinavir—CYP2C19—Prednisone—multiple sclerosis	0.018	0.0238	CbGbCtD
Indinavir—ABCB1—Mitoxantrone—multiple sclerosis	0.0175	0.0232	CbGbCtD
Indinavir—ABCB1—Betamethasone—multiple sclerosis	0.0156	0.0206	CbGbCtD
Indinavir—ABCB1—Prednisolone—multiple sclerosis	0.0154	0.0204	CbGbCtD
Indinavir—ABCB1—Prednisone—multiple sclerosis	0.0146	0.0192	CbGbCtD
Indinavir—CYP3A4—Methylprednisolone—multiple sclerosis	0.0144	0.019	CbGbCtD
Indinavir—CYP3A5—Dexamethasone—multiple sclerosis	0.014	0.0185	CbGbCtD
Indinavir—CYP2C19—Dexamethasone—multiple sclerosis	0.0113	0.0149	CbGbCtD
Indinavir—CYP3A4—Triamcinolone—multiple sclerosis	0.0109	0.0144	CbGbCtD
Indinavir—CYP3A4—Mitoxantrone—multiple sclerosis	0.0105	0.0139	CbGbCtD
Indinavir—CYP2C9—Dexamethasone—multiple sclerosis	0.00936	0.0124	CbGbCtD
Indinavir—CYP3A4—Betamethasone—multiple sclerosis	0.00936	0.0124	CbGbCtD
Indinavir—CYP3A4—Prednisolone—multiple sclerosis	0.00924	0.0122	CbGbCtD
Indinavir—ABCB1—Dexamethasone—multiple sclerosis	0.00909	0.012	CbGbCtD
Indinavir—CYP3A4—Prednisone—multiple sclerosis	0.00872	0.0115	CbGbCtD
Indinavir—CYP2D6—Dexamethasone—multiple sclerosis	0.00856	0.0113	CbGbCtD
Indinavir—ABCB1—Methotrexate—multiple sclerosis	0.0073	0.00965	CbGbCtD
Indinavir—CYP3A4—Dexamethasone—multiple sclerosis	0.00545	0.0072	CbGbCtD
Indinavir—Discomfort—Methylprednisolone—multiple sclerosis	0.000151	0.000728	CcSEcCtD
Indinavir—Headache—Azathioprine—multiple sclerosis	0.00015	0.000727	CcSEcCtD
Indinavir—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.00015	0.000727	CcSEcCtD
Indinavir—Dry mouth—Triamcinolone—multiple sclerosis	0.000149	0.000722	CcSEcCtD
Indinavir—Renal failure—Methotrexate—multiple sclerosis	0.000149	0.000721	CcSEcCtD
Indinavir—Angioedema—Betamethasone—multiple sclerosis	0.000149	0.000719	CcSEcCtD
Indinavir—Angioedema—Dexamethasone—multiple sclerosis	0.000149	0.000719	CcSEcCtD
Indinavir—Immune system disorder—Prednisone—multiple sclerosis	0.000147	0.000711	CcSEcCtD
Indinavir—Malaise—Betamethasone—multiple sclerosis	0.000147	0.00071	CcSEcCtD
Indinavir—Malaise—Dexamethasone—multiple sclerosis	0.000147	0.00071	CcSEcCtD
Indinavir—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000147	0.000708	CcSEcCtD
Indinavir—Oedema—Triamcinolone—multiple sclerosis	0.000147	0.000708	CcSEcCtD
Indinavir—Vertigo—Dexamethasone—multiple sclerosis	0.000146	0.000707	CcSEcCtD
Indinavir—Vertigo—Betamethasone—multiple sclerosis	0.000146	0.000707	CcSEcCtD
Indinavir—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000146	0.000706	CcSEcCtD
Indinavir—Syncope—Dexamethasone—multiple sclerosis	0.000146	0.000706	CcSEcCtD
Indinavir—Syncope—Betamethasone—multiple sclerosis	0.000146	0.000706	CcSEcCtD
Indinavir—Sweating—Methotrexate—multiple sclerosis	0.000145	0.000703	CcSEcCtD
Indinavir—Haematuria—Methotrexate—multiple sclerosis	0.000145	0.000699	CcSEcCtD
Indinavir—Shock—Triamcinolone—multiple sclerosis	0.000144	0.000697	CcSEcCtD
Indinavir—Insomnia—Prednisolone—multiple sclerosis	0.000144	0.000696	CcSEcCtD
Indinavir—Alopecia—Prednisone—multiple sclerosis	0.000144	0.000696	CcSEcCtD
Indinavir—Shock—Methylprednisolone—multiple sclerosis	0.000144	0.000695	CcSEcCtD
Indinavir—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000143	0.000693	CcSEcCtD
Indinavir—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000143	0.000693	CcSEcCtD
Indinavir—Loss of consciousness—Betamethasone—multiple sclerosis	0.000143	0.000692	CcSEcCtD
Indinavir—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000143	0.000692	CcSEcCtD
Indinavir—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000143	0.000691	CcSEcCtD
Indinavir—Paraesthesia—Prednisolone—multiple sclerosis	0.000143	0.000691	CcSEcCtD
Indinavir—Nausea—Azathioprine—multiple sclerosis	0.000143	0.00069	CcSEcCtD
Indinavir—Skin disorder—Methylprednisolone—multiple sclerosis	0.000142	0.000686	CcSEcCtD
Indinavir—Malnutrition—Prednisone—multiple sclerosis	0.000142	0.000685	CcSEcCtD
Indinavir—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000142	0.000684	CcSEcCtD
Indinavir—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000141	0.000683	CcSEcCtD
Indinavir—Asthenia—Mitoxantrone—multiple sclerosis	0.000139	0.000673	CcSEcCtD
Indinavir—Myalgia—Dexamethasone—multiple sclerosis	0.000139	0.00067	CcSEcCtD
Indinavir—Myalgia—Betamethasone—multiple sclerosis	0.000139	0.00067	CcSEcCtD
Indinavir—Anxiety—Dexamethasone—multiple sclerosis	0.000138	0.000668	CcSEcCtD
Indinavir—Anxiety—Betamethasone—multiple sclerosis	0.000138	0.000668	CcSEcCtD
Indinavir—Discomfort—Betamethasone—multiple sclerosis	0.000137	0.000662	CcSEcCtD
Indinavir—Discomfort—Dexamethasone—multiple sclerosis	0.000137	0.000662	CcSEcCtD
Indinavir—Haemoglobin—Methotrexate—multiple sclerosis	0.000137	0.000661	CcSEcCtD
Indinavir—Pain—Prednisolone—multiple sclerosis	0.000136	0.000658	CcSEcCtD
Indinavir—Haemorrhage—Methotrexate—multiple sclerosis	0.000136	0.000658	CcSEcCtD
Indinavir—Hepatitis—Methotrexate—multiple sclerosis	0.000136	0.000658	CcSEcCtD
Indinavir—Pharyngitis—Methotrexate—multiple sclerosis	0.000135	0.000653	CcSEcCtD
Indinavir—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000134	0.00065	CcSEcCtD
Indinavir—Vision blurred—Prednisone—multiple sclerosis	0.000134	0.000646	CcSEcCtD
Indinavir—Urethral disorder—Methotrexate—multiple sclerosis	0.000133	0.000645	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000133	0.000645	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000133	0.000644	CcSEcCtD
Indinavir—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000133	0.000642	CcSEcCtD
Indinavir—Oedema—Betamethasone—multiple sclerosis	0.000133	0.000642	CcSEcCtD
Indinavir—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000133	0.000642	CcSEcCtD
Indinavir—Oedema—Dexamethasone—multiple sclerosis	0.000133	0.000642	CcSEcCtD
Indinavir—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000133	0.000642	CcSEcCtD
Indinavir—Insomnia—Triamcinolone—multiple sclerosis	0.000133	0.00064	CcSEcCtD
Indinavir—Insomnia—Methylprednisolone—multiple sclerosis	0.000132	0.000639	CcSEcCtD
Indinavir—Ill-defined disorder—Prednisone—multiple sclerosis	0.000132	0.000636	CcSEcCtD
Indinavir—Paraesthesia—Triamcinolone—multiple sclerosis	0.000132	0.000636	CcSEcCtD
Indinavir—Feeling abnormal—Prednisolone—multiple sclerosis	0.000131	0.000634	CcSEcCtD
Indinavir—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000131	0.000634	CcSEcCtD
Indinavir—Anaemia—Prednisone—multiple sclerosis	0.000131	0.000634	CcSEcCtD
Indinavir—Shock—Dexamethasone—multiple sclerosis	0.000131	0.000632	CcSEcCtD
Indinavir—Shock—Betamethasone—multiple sclerosis	0.000131	0.000632	CcSEcCtD
Indinavir—Dyspnoea—Triamcinolone—multiple sclerosis	0.000131	0.000631	CcSEcCtD
Indinavir—Nervous system disorder—Betamethasone—multiple sclerosis	0.00013	0.00063	CcSEcCtD
Indinavir—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00013	0.00063	CcSEcCtD
Indinavir—Agitation—Prednisone—multiple sclerosis	0.00013	0.00063	CcSEcCtD
Indinavir—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.00013	0.000629	CcSEcCtD
Indinavir—Thrombocytopenia—Betamethasone—multiple sclerosis	0.00013	0.000629	CcSEcCtD
Indinavir—Angioedema—Prednisone—multiple sclerosis	0.00013	0.000626	CcSEcCtD
Indinavir—Dyspepsia—Triamcinolone—multiple sclerosis	0.000129	0.000623	CcSEcCtD
Indinavir—Erythema multiforme—Methotrexate—multiple sclerosis	0.000129	0.000622	CcSEcCtD
Indinavir—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000129	0.000622	CcSEcCtD
Indinavir—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000129	0.000621	CcSEcCtD
Indinavir—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000129	0.000621	CcSEcCtD
Indinavir—Malaise—Prednisone—multiple sclerosis	0.000128	0.000618	CcSEcCtD
Indinavir—Vertigo—Prednisone—multiple sclerosis	0.000127	0.000616	CcSEcCtD
Indinavir—Syncope—Prednisone—multiple sclerosis	0.000127	0.000615	CcSEcCtD
Indinavir—Anorexia—Betamethasone—multiple sclerosis	0.000127	0.000612	CcSEcCtD
Indinavir—Anorexia—Dexamethasone—multiple sclerosis	0.000127	0.000612	CcSEcCtD
Indinavir—Urticaria—Prednisolone—multiple sclerosis	0.000127	0.000612	CcSEcCtD
Indinavir—Fatigue—Triamcinolone—multiple sclerosis	0.000126	0.00061	CcSEcCtD
Indinavir—Fatigue—Methylprednisolone—multiple sclerosis	0.000126	0.000609	CcSEcCtD
Indinavir—Pain—Triamcinolone—multiple sclerosis	0.000125	0.000605	CcSEcCtD
Indinavir—Loss of consciousness—Prednisone—multiple sclerosis	0.000125	0.000602	CcSEcCtD
Indinavir—Vomiting—Mitoxantrone—multiple sclerosis	0.000123	0.000597	CcSEcCtD
Indinavir—Immune system disorder—Methotrexate—multiple sclerosis	0.000123	0.000594	CcSEcCtD
Indinavir—Rash—Mitoxantrone—multiple sclerosis	0.000122	0.000592	CcSEcCtD
Indinavir—Dermatitis—Mitoxantrone—multiple sclerosis	0.000122	0.000591	CcSEcCtD
Indinavir—Chills—Methotrexate—multiple sclerosis	0.000122	0.00059	CcSEcCtD
Indinavir—Headache—Mitoxantrone—multiple sclerosis	0.000122	0.000588	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000121	0.000585	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000121	0.000585	CcSEcCtD
Indinavir—Arthralgia—Prednisone—multiple sclerosis	0.000121	0.000584	CcSEcCtD
Indinavir—Myalgia—Prednisone—multiple sclerosis	0.000121	0.000584	CcSEcCtD
Indinavir—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000121	0.000583	CcSEcCtD
Indinavir—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00012	0.000582	CcSEcCtD
Indinavir—Anxiety—Prednisone—multiple sclerosis	0.00012	0.000582	CcSEcCtD
Indinavir—Alopecia—Methotrexate—multiple sclerosis	0.00012	0.000582	CcSEcCtD
Indinavir—Insomnia—Dexamethasone—multiple sclerosis	0.00012	0.000581	CcSEcCtD
Indinavir—Insomnia—Betamethasone—multiple sclerosis	0.00012	0.000581	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00012	0.00058	CcSEcCtD
Indinavir—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.00012	0.000578	CcSEcCtD
Indinavir—Paraesthesia—Dexamethasone—multiple sclerosis	0.000119	0.000577	CcSEcCtD
Indinavir—Paraesthesia—Betamethasone—multiple sclerosis	0.000119	0.000577	CcSEcCtD
Indinavir—Discomfort—Prednisone—multiple sclerosis	0.000119	0.000577	CcSEcCtD
Indinavir—Malnutrition—Methotrexate—multiple sclerosis	0.000119	0.000573	CcSEcCtD
Indinavir—Hypersensitivity—Prednisolone—multiple sclerosis	0.000117	0.000567	CcSEcCtD
Indinavir—Dyspepsia—Dexamethasone—multiple sclerosis	0.000117	0.000565	CcSEcCtD
Indinavir—Dyspepsia—Betamethasone—multiple sclerosis	0.000117	0.000565	CcSEcCtD
Indinavir—Urticaria—Triamcinolone—multiple sclerosis	0.000116	0.000562	CcSEcCtD
Indinavir—Urticaria—Methylprednisolone—multiple sclerosis	0.000116	0.000561	CcSEcCtD
Indinavir—Dysgeusia—Methotrexate—multiple sclerosis	0.000116	0.000561	CcSEcCtD
Indinavir—Body temperature increased—Triamcinolone—multiple sclerosis	0.000116	0.00056	CcSEcCtD
Indinavir—Anaphylactic shock—Prednisone—multiple sclerosis	0.000116	0.000559	CcSEcCtD
Indinavir—Oedema—Prednisone—multiple sclerosis	0.000116	0.000559	CcSEcCtD
Indinavir—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000116	0.000558	CcSEcCtD
Indinavir—Decreased appetite—Dexamethasone—multiple sclerosis	0.000116	0.000558	CcSEcCtD
Indinavir—Decreased appetite—Betamethasone—multiple sclerosis	0.000116	0.000558	CcSEcCtD
Indinavir—Nausea—Mitoxantrone—multiple sclerosis	0.000115	0.000557	CcSEcCtD
Indinavir—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000115	0.000555	CcSEcCtD
Indinavir—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000115	0.000555	CcSEcCtD
Indinavir—Back pain—Methotrexate—multiple sclerosis	0.000115	0.000554	CcSEcCtD
Indinavir—Fatigue—Dexamethasone—multiple sclerosis	0.000115	0.000554	CcSEcCtD
Indinavir—Fatigue—Betamethasone—multiple sclerosis	0.000115	0.000554	CcSEcCtD
Indinavir—Shock—Prednisone—multiple sclerosis	0.000114	0.00055	CcSEcCtD
Indinavir—Pain—Dexamethasone—multiple sclerosis	0.000114	0.000549	CcSEcCtD
Indinavir—Pain—Betamethasone—multiple sclerosis	0.000114	0.000549	CcSEcCtD
Indinavir—Nervous system disorder—Prednisone—multiple sclerosis	0.000114	0.000549	CcSEcCtD
Indinavir—Skin disorder—Prednisone—multiple sclerosis	0.000112	0.000543	CcSEcCtD
Indinavir—Hyperhidrosis—Prednisone—multiple sclerosis	0.000112	0.000541	CcSEcCtD
Indinavir—Vision blurred—Methotrexate—multiple sclerosis	0.000112	0.00054	CcSEcCtD
Indinavir—Anorexia—Prednisone—multiple sclerosis	0.00011	0.000533	CcSEcCtD
Indinavir—Ill-defined disorder—Methotrexate—multiple sclerosis	0.00011	0.000532	CcSEcCtD
Indinavir—Anaemia—Methotrexate—multiple sclerosis	0.00011	0.000529	CcSEcCtD
Indinavir—Feeling abnormal—Betamethasone—multiple sclerosis	0.00011	0.000529	CcSEcCtD
Indinavir—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00011	0.000529	CcSEcCtD
Indinavir—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000109	0.000525	CcSEcCtD
Indinavir—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000109	0.000525	CcSEcCtD
Indinavir—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000108	0.000522	CcSEcCtD
Indinavir—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000108	0.00052	CcSEcCtD
Indinavir—SLC22A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000107	0.00295	CbGpPWpGaD
Indinavir—Malaise—Methotrexate—multiple sclerosis	0.000107	0.000517	CcSEcCtD
Indinavir—Vertigo—Methotrexate—multiple sclerosis	0.000107	0.000515	CcSEcCtD
Indinavir—Urticaria—Betamethasone—multiple sclerosis	0.000106	0.00051	CcSEcCtD
Indinavir—Urticaria—Dexamethasone—multiple sclerosis	0.000106	0.00051	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000105	0.00051	CcSEcCtD
Indinavir—Dizziness—Prednisolone—multiple sclerosis	0.000105	0.000509	CcSEcCtD
Indinavir—Asthenia—Triamcinolone—multiple sclerosis	0.000105	0.000508	CcSEcCtD
Indinavir—Body temperature increased—Betamethasone—multiple sclerosis	0.000105	0.000508	CcSEcCtD
Indinavir—Abdominal pain—Dexamethasone—multiple sclerosis	0.000105	0.000508	CcSEcCtD
Indinavir—Abdominal pain—Betamethasone—multiple sclerosis	0.000105	0.000508	CcSEcCtD
Indinavir—Body temperature increased—Dexamethasone—multiple sclerosis	0.000105	0.000508	CcSEcCtD
Indinavir—Asthenia—Methylprednisolone—multiple sclerosis	0.000105	0.000507	CcSEcCtD
Indinavir—Insomnia—Prednisone—multiple sclerosis	0.000105	0.000506	CcSEcCtD
Indinavir—Paraesthesia—Prednisone—multiple sclerosis	0.000104	0.000502	CcSEcCtD
Indinavir—Pruritus—Triamcinolone—multiple sclerosis	0.000104	0.000501	CcSEcCtD
Indinavir—Cough—Methotrexate—multiple sclerosis	0.000103	0.0005	CcSEcCtD
Indinavir—Pruritus—Methylprednisolone—multiple sclerosis	0.000103	0.0005	CcSEcCtD
Indinavir—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000103	0.00283	CbGpPWpGaD
Indinavir—SLCO1A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000103	0.00283	CbGpPWpGaD
Indinavir—Dyspepsia—Prednisone—multiple sclerosis	0.000102	0.000492	CcSEcCtD
Indinavir—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	0.000101	0.00279	CbGpPWpGaD
Indinavir—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	0.000101	0.00279	CbGpPWpGaD
Indinavir—Arthralgia—Methotrexate—multiple sclerosis	0.000101	0.000488	CcSEcCtD
Indinavir—Chest pain—Methotrexate—multiple sclerosis	0.000101	0.000488	CcSEcCtD
Indinavir—Myalgia—Methotrexate—multiple sclerosis	0.000101	0.000488	CcSEcCtD
Indinavir—Decreased appetite—Prednisone—multiple sclerosis	0.000101	0.000486	CcSEcCtD
Indinavir—Rash—Prednisolone—multiple sclerosis	0.0001	0.000485	CcSEcCtD
Indinavir—Dermatitis—Prednisolone—multiple sclerosis	0.0001	0.000485	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.0001	0.000484	CcSEcCtD
Indinavir—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.0001	0.00276	CbGpPWpGaD
Indinavir—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.0001	0.00276	CbGpPWpGaD
Indinavir—Diarrhoea—Methylprednisolone—multiple sclerosis	0.0001	0.000483	CcSEcCtD
Indinavir—Fatigue—Prednisone—multiple sclerosis	9.98e-05	0.000482	CcSEcCtD
Indinavir—Headache—Prednisolone—multiple sclerosis	9.98e-05	0.000482	CcSEcCtD
Indinavir—Discomfort—Methotrexate—multiple sclerosis	9.97e-05	0.000482	CcSEcCtD
Indinavir—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	9.96e-05	0.00275	CbGpPWpGaD
Indinavir—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	9.96e-05	0.00275	CbGpPWpGaD
Indinavir—Constipation—Prednisone—multiple sclerosis	9.9e-05	0.000478	CcSEcCtD
Indinavir—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	9.88e-05	0.00272	CbGpPWpGaD
Indinavir—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	9.88e-05	0.00272	CbGpPWpGaD
Indinavir—SLCO1A2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	9.84e-05	0.00271	CbGpPWpGaD
Indinavir—Dizziness—Triamcinolone—multiple sclerosis	9.69e-05	0.000468	CcSEcCtD
Indinavir—Anaphylactic shock—Methotrexate—multiple sclerosis	9.68e-05	0.000468	CcSEcCtD
Indinavir—Dizziness—Methylprednisolone—multiple sclerosis	9.67e-05	0.000467	CcSEcCtD
Indinavir—SLCO1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	9.62e-05	0.00265	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	9.62e-05	0.00265	CbGpPWpGaD
Indinavir—Feeling abnormal—Prednisone—multiple sclerosis	9.54e-05	0.000461	CcSEcCtD
Indinavir—Asthenia—Betamethasone—multiple sclerosis	9.54e-05	0.000461	CcSEcCtD
Indinavir—Asthenia—Dexamethasone—multiple sclerosis	9.54e-05	0.000461	CcSEcCtD
Indinavir—Nervous system disorder—Methotrexate—multiple sclerosis	9.49e-05	0.000459	CcSEcCtD
Indinavir—Thrombocytopenia—Methotrexate—multiple sclerosis	9.47e-05	0.000458	CcSEcCtD
Indinavir—Gastrointestinal pain—Prednisone—multiple sclerosis	9.47e-05	0.000457	CcSEcCtD
Indinavir—Nausea—Prednisolone—multiple sclerosis	9.46e-05	0.000457	CcSEcCtD
Indinavir—Pruritus—Betamethasone—multiple sclerosis	9.41e-05	0.000454	CcSEcCtD
Indinavir—Pruritus—Dexamethasone—multiple sclerosis	9.41e-05	0.000454	CcSEcCtD
Indinavir—Skin disorder—Methotrexate—multiple sclerosis	9.4e-05	0.000454	CcSEcCtD
Indinavir—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	9.35e-05	0.00258	CbGpPWpGaD
Indinavir—Hyperhidrosis—Methotrexate—multiple sclerosis	9.35e-05	0.000452	CcSEcCtD
Indinavir—Vomiting—Triamcinolone—multiple sclerosis	9.32e-05	0.00045	CcSEcCtD
Indinavir—Vomiting—Methylprednisolone—multiple sclerosis	9.29e-05	0.000449	CcSEcCtD
Indinavir—Rash—Triamcinolone—multiple sclerosis	9.24e-05	0.000446	CcSEcCtD
Indinavir—Dermatitis—Triamcinolone—multiple sclerosis	9.23e-05	0.000446	CcSEcCtD
Indinavir—Anorexia—Methotrexate—multiple sclerosis	9.22e-05	0.000446	CcSEcCtD
Indinavir—Rash—Methylprednisolone—multiple sclerosis	9.22e-05	0.000445	CcSEcCtD
Indinavir—Dermatitis—Methylprednisolone—multiple sclerosis	9.21e-05	0.000445	CcSEcCtD
Indinavir—Urticaria—Prednisone—multiple sclerosis	9.2e-05	0.000444	CcSEcCtD
Indinavir—Headache—Triamcinolone—multiple sclerosis	9.18e-05	0.000444	CcSEcCtD
Indinavir—Headache—Methylprednisolone—multiple sclerosis	9.16e-05	0.000443	CcSEcCtD
Indinavir—Abdominal pain—Prednisone—multiple sclerosis	9.15e-05	0.000442	CcSEcCtD
Indinavir—Body temperature increased—Prednisone—multiple sclerosis	9.15e-05	0.000442	CcSEcCtD
Indinavir—Diarrhoea—Dexamethasone—multiple sclerosis	9.1e-05	0.00044	CcSEcCtD
Indinavir—Diarrhoea—Betamethasone—multiple sclerosis	9.1e-05	0.00044	CcSEcCtD
Indinavir—ABCB1—Allograft Rejection—CD28—multiple sclerosis	9.09e-05	0.00251	CbGpPWpGaD
Indinavir—ABCC2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	8.96e-05	0.00247	CbGpPWpGaD
Indinavir—ABCC1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	8.85e-05	0.00244	CbGpPWpGaD
Indinavir—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	8.81e-05	0.000426	CcSEcCtD
Indinavir—Dizziness—Dexamethasone—multiple sclerosis	8.79e-05	0.000425	CcSEcCtD
Indinavir—Dizziness—Betamethasone—multiple sclerosis	8.79e-05	0.000425	CcSEcCtD
Indinavir—SLCO1B1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	8.77e-05	0.00242	CbGpPWpGaD
Indinavir—Insomnia—Methotrexate—multiple sclerosis	8.75e-05	0.000423	CcSEcCtD
Indinavir—Nausea—Triamcinolone—multiple sclerosis	8.7e-05	0.000421	CcSEcCtD
Indinavir—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	8.7e-05	0.0024	CbGpPWpGaD
Indinavir—Paraesthesia—Methotrexate—multiple sclerosis	8.69e-05	0.00042	CcSEcCtD
Indinavir—Nausea—Methylprednisolone—multiple sclerosis	8.68e-05	0.00042	CcSEcCtD
Indinavir—ABCC1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	8.65e-05	0.00239	CbGpPWpGaD
Indinavir—ABCC1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	8.65e-05	0.00239	CbGpPWpGaD
Indinavir—Dyspnoea—Methotrexate—multiple sclerosis	8.63e-05	0.000417	CcSEcCtD
Indinavir—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	8.62e-05	0.00238	CbGpPWpGaD
Indinavir—Somnolence—Methotrexate—multiple sclerosis	8.6e-05	0.000416	CcSEcCtD
Indinavir—Hypersensitivity—Prednisone—multiple sclerosis	8.53e-05	0.000412	CcSEcCtD
Indinavir—Dyspepsia—Methotrexate—multiple sclerosis	8.52e-05	0.000412	CcSEcCtD
Indinavir—Vomiting—Dexamethasone—multiple sclerosis	8.45e-05	0.000408	CcSEcCtD
Indinavir—Vomiting—Betamethasone—multiple sclerosis	8.45e-05	0.000408	CcSEcCtD
Indinavir—SLCO1B1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	8.41e-05	0.00232	CbGpPWpGaD
Indinavir—Decreased appetite—Methotrexate—multiple sclerosis	8.41e-05	0.000406	CcSEcCtD
Indinavir—Rash—Dexamethasone—multiple sclerosis	8.38e-05	0.000405	CcSEcCtD
Indinavir—Rash—Betamethasone—multiple sclerosis	8.38e-05	0.000405	CcSEcCtD
Indinavir—Dermatitis—Betamethasone—multiple sclerosis	8.37e-05	0.000405	CcSEcCtD
Indinavir—Dermatitis—Dexamethasone—multiple sclerosis	8.37e-05	0.000405	CcSEcCtD
Indinavir—Gastrointestinal disorder—Methotrexate—multiple sclerosis	8.35e-05	0.000404	CcSEcCtD
Indinavir—Fatigue—Methotrexate—multiple sclerosis	8.34e-05	0.000403	CcSEcCtD
Indinavir—Headache—Betamethasone—multiple sclerosis	8.33e-05	0.000402	CcSEcCtD
Indinavir—Headache—Dexamethasone—multiple sclerosis	8.33e-05	0.000402	CcSEcCtD
Indinavir—CYP3A7—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.32e-05	0.00229	CbGpPWpGaD
Indinavir—Asthenia—Prednisone—multiple sclerosis	8.31e-05	0.000401	CcSEcCtD
Indinavir—ABCB1—Allograft Rejection—CD40—multiple sclerosis	8.3e-05	0.00229	CbGpPWpGaD
Indinavir—Pain—Methotrexate—multiple sclerosis	8.27e-05	0.0004	CcSEcCtD
Indinavir—SLCO1B1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	8.22e-05	0.00227	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	8.22e-05	0.00227	CbGpPWpGaD
Indinavir—Pruritus—Prednisone—multiple sclerosis	8.19e-05	0.000396	CcSEcCtD
Indinavir—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	8.18e-05	0.00225	CbGpPWpGaD
Indinavir—Feeling abnormal—Methotrexate—multiple sclerosis	7.97e-05	0.000385	CcSEcCtD
Indinavir—Diarrhoea—Prednisone—multiple sclerosis	7.92e-05	0.000383	CcSEcCtD
Indinavir—Gastrointestinal pain—Methotrexate—multiple sclerosis	7.91e-05	0.000382	CcSEcCtD
Indinavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	7.9e-05	0.00218	CbGpPWpGaD
Indinavir—Nausea—Betamethasone—multiple sclerosis	7.9e-05	0.000382	CcSEcCtD
Indinavir—Nausea—Dexamethasone—multiple sclerosis	7.9e-05	0.000382	CcSEcCtD
Indinavir—Urticaria—Methotrexate—multiple sclerosis	7.69e-05	0.000371	CcSEcCtD
Indinavir—Dizziness—Prednisone—multiple sclerosis	7.66e-05	0.00037	CcSEcCtD
Indinavir—Abdominal pain—Methotrexate—multiple sclerosis	7.65e-05	0.00037	CcSEcCtD
Indinavir—Body temperature increased—Methotrexate—multiple sclerosis	7.65e-05	0.00037	CcSEcCtD
Indinavir—SLC22A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	7.49e-05	0.00206	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	7.47e-05	0.00206	CbGpPWpGaD
Indinavir—SLCO1A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	7.45e-05	0.00206	CbGpPWpGaD
Indinavir—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.42e-05	0.00205	CbGpPWpGaD
Indinavir—Vomiting—Prednisone—multiple sclerosis	7.36e-05	0.000356	CcSEcCtD
Indinavir—Rash—Prednisone—multiple sclerosis	7.3e-05	0.000353	CcSEcCtD
Indinavir—Dermatitis—Prednisone—multiple sclerosis	7.29e-05	0.000352	CcSEcCtD
Indinavir—Headache—Prednisone—multiple sclerosis	7.25e-05	0.00035	CcSEcCtD
Indinavir—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	7.2e-05	0.00198	CbGpPWpGaD
Indinavir—SLC22A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	7.18e-05	0.00198	CbGpPWpGaD
Indinavir—Hypersensitivity—Methotrexate—multiple sclerosis	7.13e-05	0.000344	CcSEcCtD
Indinavir—SLC22A1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	7.06e-05	0.00195	CbGpPWpGaD
Indinavir—Asthenia—Methotrexate—multiple sclerosis	6.94e-05	0.000335	CcSEcCtD
Indinavir—Nausea—Prednisone—multiple sclerosis	6.88e-05	0.000332	CcSEcCtD
Indinavir—Pruritus—Methotrexate—multiple sclerosis	6.85e-05	0.000331	CcSEcCtD
Indinavir—ABCC2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.79e-05	0.00187	CbGpPWpGaD
Indinavir—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	6.73e-05	0.00186	CbGpPWpGaD
Indinavir—ABCC1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.71e-05	0.00185	CbGpPWpGaD
Indinavir—Diarrhoea—Methotrexate—multiple sclerosis	6.62e-05	0.00032	CcSEcCtD
Indinavir—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	6.61e-05	0.00182	CbGpPWpGaD
Indinavir—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	6.61e-05	0.00182	CbGpPWpGaD
Indinavir—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	6.51e-05	0.0018	CbGpPWpGaD
Indinavir—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	6.51e-05	0.0018	CbGpPWpGaD
Indinavir—ABCB1—Allograft Rejection—CD86—multiple sclerosis	6.48e-05	0.00179	CbGpPWpGaD
Indinavir—Dizziness—Methotrexate—multiple sclerosis	6.4e-05	0.000309	CcSEcCtD
Indinavir—SLCO1B1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.37e-05	0.00176	CbGpPWpGaD
Indinavir—ABCB1—Allograft Rejection—IL10—multiple sclerosis	6.36e-05	0.00175	CbGpPWpGaD
Indinavir—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	6.36e-05	0.00175	CbGpPWpGaD
Indinavir—ABCB1—Allograft Rejection—IL4—multiple sclerosis	6.19e-05	0.00171	CbGpPWpGaD
Indinavir—Vomiting—Methotrexate—multiple sclerosis	6.15e-05	0.000297	CcSEcCtD
Indinavir—Rash—Methotrexate—multiple sclerosis	6.1e-05	0.000295	CcSEcCtD
Indinavir—Dermatitis—Methotrexate—multiple sclerosis	6.09e-05	0.000295	CcSEcCtD
Indinavir—SLCO1A2—Metabolism—SRM—multiple sclerosis	6.08e-05	0.00168	CbGpPWpGaD
Indinavir—Headache—Methotrexate—multiple sclerosis	6.06e-05	0.000293	CcSEcCtD
Indinavir—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	6.05e-05	0.00167	CbGpPWpGaD
Indinavir—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.02e-05	0.00166	CbGpPWpGaD
Indinavir—SLCO1A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.89e-05	0.00162	CbGpPWpGaD
Indinavir—Nausea—Methotrexate—multiple sclerosis	5.75e-05	0.000278	CcSEcCtD
Indinavir—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.74e-05	0.00158	CbGpPWpGaD
Indinavir—ABCB1—Allograft Rejection—FAS—multiple sclerosis	5.7e-05	0.00157	CbGpPWpGaD
Indinavir—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	5.67e-05	0.00156	CbGpPWpGaD
Indinavir—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	5.6e-05	0.00154	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—SRM—multiple sclerosis	5.47e-05	0.00151	CbGpPWpGaD
Indinavir—SLC22A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.44e-05	0.0015	CbGpPWpGaD
Indinavir—SLC22A1—Neuronal System—BCHE—multiple sclerosis	5.41e-05	0.00149	CbGpPWpGaD
Indinavir—ABCC2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.36e-05	0.00148	CbGpPWpGaD
Indinavir—ABCC1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.3e-05	0.00146	CbGpPWpGaD
Indinavir—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.28e-05	0.00146	CbGpPWpGaD
Indinavir—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.23e-05	0.00144	CbGpPWpGaD
Indinavir—SLCO1A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.21e-05	0.00144	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—SRM—multiple sclerosis	5.2e-05	0.00143	CbGpPWpGaD
Indinavir—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	5.12e-05	0.00141	CbGpPWpGaD
Indinavir—SLCO1B1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.04e-05	0.00139	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—SRM—multiple sclerosis	4.77e-05	0.00132	CbGpPWpGaD
Indinavir—ABCC2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.74e-05	0.00131	CbGpPWpGaD
Indinavir—ABCB1—Allograft Rejection—CD80—multiple sclerosis	4.73e-05	0.0013	CbGpPWpGaD
Indinavir—ABCC1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.69e-05	0.00129	CbGpPWpGaD
Indinavir—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.65e-05	0.00128	CbGpPWpGaD
Indinavir—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.45e-05	0.00123	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—SRM—multiple sclerosis	4.44e-05	0.00122	CbGpPWpGaD
Indinavir—CYP3A7—Biological oxidations—POMC—multiple sclerosis	4.42e-05	0.00122	CbGpPWpGaD
Indinavir—SLC22A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.3e-05	0.00119	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—CYP27B1—multiple sclerosis	4.28e-05	0.00118	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—CYP24A1—multiple sclerosis	4.28e-05	0.00118	CbGpPWpGaD
Indinavir—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.28e-05	0.00118	CbGpPWpGaD
Indinavir—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.24e-05	0.00117	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.22e-05	0.00116	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.22e-05	0.00116	CbGpPWpGaD
Indinavir—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.21e-05	0.00116	CbGpPWpGaD
Indinavir—ABCC1—Disease—GPC5—multiple sclerosis	4.21e-05	0.00116	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.19e-05	0.00115	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	4.09e-05	0.00113	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—GPC5—multiple sclerosis	3.92e-05	0.00108	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—CYP27B1—multiple sclerosis	3.85e-05	0.00106	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—CYP24A1—multiple sclerosis	3.85e-05	0.00106	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.85e-05	0.00106	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.85e-05	0.00106	CbGpPWpGaD
Indinavir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	3.81e-05	0.00105	CbGpPWpGaD
Indinavir—SLC22A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.8e-05	0.00105	CbGpPWpGaD
Indinavir—ABCC1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.77e-05	0.00104	CbGpPWpGaD
Indinavir—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	3.74e-05	0.00103	CbGpPWpGaD
Indinavir—SLCO1A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.69e-05	0.00102	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—CYP24A1—multiple sclerosis	3.66e-05	0.00101	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—CYP27B1—multiple sclerosis	3.66e-05	0.00101	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.58e-05	0.000987	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—GPC5—multiple sclerosis	3.52e-05	0.000972	CbGpPWpGaD
Indinavir—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.45e-05	0.000951	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—SRM—multiple sclerosis	3.45e-05	0.000951	CbGpPWpGaD
Indinavir—ABCC2—NRF2 pathway—TGFB1—multiple sclerosis	3.37e-05	0.00093	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	3.36e-05	0.000927	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	3.36e-05	0.000927	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—GPC5—multiple sclerosis	3.35e-05	0.000924	CbGpPWpGaD
Indinavir—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	3.33e-05	0.000919	CbGpPWpGaD
Indinavir—ABCB1—Allograft Rejection—IL2—multiple sclerosis	3.32e-05	0.000916	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	3.29e-05	0.000906	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—RRM1—multiple sclerosis	3.25e-05	0.000895	CbGpPWpGaD
Indinavir—CYP3A5—Biological oxidations—POMC—multiple sclerosis	3.2e-05	0.000881	CbGpPWpGaD
Indinavir—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.19e-05	0.00088	CbGpPWpGaD
Indinavir—SLCO1B1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.16e-05	0.00087	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—CYP24A1—multiple sclerosis	3.13e-05	0.000862	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—CYP27B1—multiple sclerosis	3.13e-05	0.000862	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—GPC5—multiple sclerosis	3.07e-05	0.000848	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—RRM1—multiple sclerosis	2.92e-05	0.000805	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—GPC5—multiple sclerosis	2.86e-05	0.000789	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.81e-05	0.000776	CbGpPWpGaD
Indinavir—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.8e-05	0.000771	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—RRM1—multiple sclerosis	2.78e-05	0.000765	CbGpPWpGaD
Indinavir—ABCC1—Disease—RPL5—multiple sclerosis	2.74e-05	0.000755	CbGpPWpGaD
Indinavir—SLC22A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.7e-05	0.000743	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—SRM—multiple sclerosis	2.67e-05	0.000735	CbGpPWpGaD
Indinavir—ABCC1—Disease—SLC11A1—multiple sclerosis	2.62e-05	0.000723	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—SRM—multiple sclerosis	2.6e-05	0.000717	CbGpPWpGaD
Indinavir—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	2.59e-05	0.000715	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—RRM1—multiple sclerosis	2.55e-05	0.000702	CbGpPWpGaD
Indinavir—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.52e-05	0.000695	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.52e-05	0.000694	CbGpPWpGaD
Indinavir—CYP2C19—Biological oxidations—POMC—multiple sclerosis	2.47e-05	0.000681	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—SRM—multiple sclerosis	2.45e-05	0.000676	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—SRM—multiple sclerosis	2.43e-05	0.00067	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	2.43e-05	0.00067	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	2.43e-05	0.00067	CbGpPWpGaD
Indinavir—ABCB1—Allograft Rejection—TNF—multiple sclerosis	2.42e-05	0.000667	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—RRM1—multiple sclerosis	2.37e-05	0.000654	CbGpPWpGaD
Indinavir—CYP2D6—Biological oxidations—POMC—multiple sclerosis	2.27e-05	0.000627	CbGpPWpGaD
Indinavir—ABCC1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.27e-05	0.000625	CbGpPWpGaD
Indinavir—CYP2C9—Biological oxidations—POMC—multiple sclerosis	2.25e-05	0.000621	CbGpPWpGaD
Indinavir—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.23e-05	0.000615	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—GPC5—multiple sclerosis	2.22e-05	0.000613	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.16e-05	0.000596	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.15e-05	0.000594	CbGpPWpGaD
Indinavir—ABCC1—Disease—CD28—multiple sclerosis	2.09e-05	0.000577	CbGpPWpGaD
Indinavir—SLC22A1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.06e-05	0.000569	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.97e-05	0.000544	CbGpPWpGaD
Indinavir—ABCC1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.95e-05	0.000537	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	1.88e-05	0.000518	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	1.88e-05	0.000518	CbGpPWpGaD
Indinavir—SLCO1A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.88e-05	0.000517	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—BCHE—multiple sclerosis	1.86e-05	0.000514	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.85e-05	0.00051	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—RRM1—multiple sclerosis	1.84e-05	0.000508	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.84e-05	0.000506	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CYP24A1—multiple sclerosis	1.83e-05	0.000505	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CYP27B1—multiple sclerosis	1.83e-05	0.000505	CbGpPWpGaD
Indinavir—ABCC1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.77e-05	0.000489	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	1.73e-05	0.000476	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	1.73e-05	0.000476	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GPC5—multiple sclerosis	1.72e-05	0.000474	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.71e-05	0.000472	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.71e-05	0.000472	CbGpPWpGaD
Indinavir—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.71e-05	0.000471	CbGpPWpGaD
Indinavir—ABCC1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.69e-05	0.000465	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.69e-05	0.000465	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—BCHE—multiple sclerosis	1.68e-05	0.000463	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GPC5—multiple sclerosis	1.68e-05	0.000462	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.67e-05	0.000462	CbGpPWpGaD
Indinavir—SLCO1B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.6e-05	0.000442	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—SRM—multiple sclerosis	1.6e-05	0.000442	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—BCHE—multiple sclerosis	1.59e-05	0.00044	CbGpPWpGaD
Indinavir—SLC22A1—Neuronal System—MAPK1—multiple sclerosis	1.58e-05	0.000436	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.58e-05	0.000436	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.57e-05	0.000432	CbGpPWpGaD
Indinavir—ABCC1—Disease—CD86—multiple sclerosis	1.49e-05	0.000412	CbGpPWpGaD
Indinavir—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.49e-05	0.00041	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—BCHE—multiple sclerosis	1.46e-05	0.000403	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.42e-05	0.000392	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—RRM1—multiple sclerosis	1.39e-05	0.000383	CbGpPWpGaD
Indinavir—SLC22A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.37e-05	0.000378	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—BCHE—multiple sclerosis	1.36e-05	0.000375	CbGpPWpGaD
Indinavir—ABCC1—Disease—CCR5—multiple sclerosis	1.32e-05	0.000365	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.31e-05	0.000361	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.3e-05	0.000358	CbGpPWpGaD
Indinavir—ABCC1—Disease—HLA-A—multiple sclerosis	1.29e-05	0.000356	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.28e-05	0.000353	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.28e-05	0.000353	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.25e-05	0.000346	CbGpPWpGaD
Indinavir—ABCC1—Disease—APOE—multiple sclerosis	1.2e-05	0.000332	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.19e-05	0.000329	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.13e-05	0.000311	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.13e-05	0.000311	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—APOE—multiple sclerosis	1.12e-05	0.000309	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.1e-05	0.000305	CbGpPWpGaD
Indinavir—ABCC1—Disease—CD80—multiple sclerosis	1.09e-05	0.0003	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.06e-05	0.000292	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.03e-05	0.000285	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—APOE—multiple sclerosis	1.01e-05	0.000278	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.01e-05	0.000278	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—POMC—multiple sclerosis	9.63e-06	0.000266	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—APOE—multiple sclerosis	9.59e-06	0.000264	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.49e-06	0.000262	CbGpPWpGaD
Indinavir—ABCC1—Disease—TYK2—multiple sclerosis	9.2e-06	0.000254	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—APOE—multiple sclerosis	8.8e-06	0.000243	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—ALB—multiple sclerosis	8.78e-06	0.000242	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—POMC—multiple sclerosis	8.67e-06	0.000239	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.65e-06	0.000239	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.65e-06	0.000238	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—RRM1—multiple sclerosis	8.56e-06	0.000236	CbGpPWpGaD
Indinavir—ABCC1—Disease—CD4—multiple sclerosis	8.32e-06	0.000229	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—POMC—multiple sclerosis	8.24e-06	0.000227	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—APOE—multiple sclerosis	8.19e-06	0.000226	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—BCHE—multiple sclerosis	8.18e-06	0.000225	CbGpPWpGaD
Indinavir—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.03e-06	0.000221	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—BCHE—multiple sclerosis	7.98e-06	0.00022	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—ALB—multiple sclerosis	7.9e-06	0.000218	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.89e-06	0.000217	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—POMC—multiple sclerosis	7.56e-06	0.000208	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—BCHE—multiple sclerosis	7.52e-06	0.000207	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—ALB—multiple sclerosis	7.51e-06	0.000207	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—BCHE—multiple sclerosis	7.46e-06	0.000206	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—POMC—multiple sclerosis	7.04e-06	0.000194	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—ALB—multiple sclerosis	6.89e-06	0.00019	CbGpPWpGaD
Indinavir—ABCC1—Disease—STAT3—multiple sclerosis	6.44e-06	0.000178	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—ALB—multiple sclerosis	6.42e-06	0.000177	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—APOE—multiple sclerosis	6.36e-06	0.000175	CbGpPWpGaD
Indinavir—ABCC1—Disease—MYC—multiple sclerosis	5.98e-06	0.000165	CbGpPWpGaD
Indinavir—ABCC1—Disease—TGFB1—multiple sclerosis	5.97e-06	0.000165	CbGpPWpGaD
Indinavir—ABCC1—Disease—MAPK1—multiple sclerosis	5.85e-06	0.000161	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—POMC—multiple sclerosis	5.47e-06	0.000151	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—ALB—multiple sclerosis	4.98e-06	0.000137	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—APOE—multiple sclerosis	4.92e-06	0.000136	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—BCHE—multiple sclerosis	4.92e-06	0.000136	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—APOE—multiple sclerosis	4.8e-06	0.000132	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—APOE—multiple sclerosis	4.52e-06	0.000125	CbGpPWpGaD
Indinavir—ABCC1—Disease—IL6—multiple sclerosis	4.5e-06	0.000124	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—APOE—multiple sclerosis	4.48e-06	0.000124	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—POMC—multiple sclerosis	4.23e-06	0.000117	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—POMC—multiple sclerosis	4.12e-06	0.000114	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—POMC—multiple sclerosis	3.89e-06	0.000107	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—POMC—multiple sclerosis	3.85e-06	0.000106	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—ALB—multiple sclerosis	3.85e-06	0.000106	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—ALB—multiple sclerosis	3.76e-06	0.000104	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ALB—multiple sclerosis	3.54e-06	9.77e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ALB—multiple sclerosis	3.51e-06	9.68e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—APOE—multiple sclerosis	2.96e-06	8.16e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—POMC—multiple sclerosis	2.54e-06	7.01e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ALB—multiple sclerosis	2.32e-06	6.39e-05	CbGpPWpGaD
